- $407.02m
- $497.71m
- $54.33m
- 16
- 21
- 46
- 16
Annual cashflow statement for Carlsmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -18.9 | -24.3 |
| Depreciation | ||
| Non-Cash Items | 2.17 | 2.72 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.893 | -4.08 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -35 | -50.9 |
| Capital Expenditures | -0.135 | -0.18 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | -0.27 | -0.36 |
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 6.36 | 117 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -14.4 | 32.9 |